Informação sobre produto
- N2-[1,4-Dioxo-4-[[4-(4-oxo-8-phenyl-4H-1-benzopyran-2-yl)morpholinium-4-yl]methoxy]butyl]-L-arginylglycyl-L-α-aspartyl-L-serine
- inn er salt
SF 1126 is a potent inhibitor of the PI3K/Akt/mTOR signaling pathway, which plays a crucial role in regulating cell growth and survival. This compound induces apoptosis in cancer cells by inhibiting the activity of kinase enzymes that are involved in tumor progression. SF 1126 has been shown to inhibit the secretion of secretin, a hormone that stimulates pancreatic exocrine secretion, and also inhibits xylanase activity. This compound has demonstrated antitumor effects against various types of cancer, including breast, lung, and colon cancer. Additionally, SF 1126 has been found to be an analog of saxagliptin and aprepitant, two drugs used for the treatment of diabetes and chemotherapy-induced nausea and vomiting respectively. The potential therapeutic benefits of SF 1126 make it a promising candidate for the development of new cancer treatments.
Propriedades químicas
Consulta técnica sobre: 3D-BS183202 SF 1126
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
